ANI Pharmaceuticals (ANIP)

[pcinsurto]

Cantor Concerns...

Uncertainty around the strategy that a new permanent CEO will bring.
-BOD aware this move would bring uncertainty. Had to be a valid reason. No cause termination clears any ill actions that AP may have done.

FDA refuse to file letter of Cortrophin Gel.
-Last public announcement addressed this. Will be resolved.

Uncertainty that COVID-19 has placed on all company base businesses.
-Master of the obvious. LOL, sorry CF.

My Opinion... Correct call to be cautious. However, stellar earnings. Fundamentally strong. New CEO will come and maybe a household name from major Pharma. Also may get some M&A activity.

I agree with the market perform until we get clarity. I don't agree w/ the $40.00 price. To me its a target and not an evaluation.

LONG AND STRONG!